The consortium will develop an innovative diagnostic test to assess the risk of post-acute myocardial infarction(AMI) patients to develop life threatening heart failure (HF). A recently discovered prognostic set of 4 miRNAs will be validated and strengthened for use in a clinical test. Together with clinical information from the patient, them iRNA test will be developed into a new prognostic model for the identification of patients at risk to allow early treatment an monitor treatment response.
|Effective start/end date
|1/01/15 → 31/01/19
- FNR - Fonds National de la Recherche: €299,000.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.